Total Funding
55
55
Total FundingPost-IPO Equity raised
Growth Score
-8 pts
Heat Score
15 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
4305
CAMP4 Therapeutics is a biotechnology company that uses RNA to restore healthy gene expression.
- Leonard Zon: FounderPast Role: Harvard Medical School, Grousbeck Professor of Pediatric Medicine
About the Company
CAMP4 is focused on addressing the fundamental cause of disease by controlling the output of genes central to disease. By taking advantage of the gene circuitry code, CAMP4 is able to control gene production through signaling pathways the cell is already utilizing to regulate gene expression. Their predictions enables CAMP4 to have a rapid start to
disease treatment, significantly reducing the time and risk to bring new medicines to patients.
